KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kimberly Clark (KMB) Cash & Equivalents (2016 - 2025)

Kimberly Clark (KMB) has 17 years of Cash & Equivalents data on record, last reported at $688.0 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 31.88% year-over-year to $688.0 million; the TTM value through Dec 2025 reached $688.0 million, down 31.88%, while the annual FY2025 figure was $688.0 million, 31.88% down from the prior year.
  • Cash & Equivalents reached $688.0 million in Q4 2025 per KMB's latest filing, up from $617.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.2 billion in Q2 2024 and bottomed at $270.0 million in Q4 2021.
  • Average Cash & Equivalents over 5 years is $621.2 million, with a median of $571.5 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: crashed 81.16% in 2021, then surged 155.97% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $270.0 million in 2021, then surged by 58.15% to $427.0 million in 2022, then soared by 155.97% to $1.1 billion in 2023, then dropped by 7.59% to $1.0 billion in 2024, then crashed by 31.88% to $688.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $688.0 million in Q4 2025, $617.0 million in Q3 2025, and $634.0 million in Q2 2025.